Skip to main content
. 2015 Jul 17;10(7):e0132332. doi: 10.1371/journal.pone.0132332

Table 3. Stratification analyses of NBS1 Polymorphism with CRC risk in the discovery set.

Variables Cases (763) Controls (892) Adjusted OR (95% CI) a P value b
GG+GC(N) (%) CC(N) (%) GG+GC(N) (%) CC(N) (%) GG+GC VS CC
Age (years)
≤60 304 (39.84) 121 (15.86) 389 (43.61) 109 (12.22) 1.42 (1.07–1.93) 0.29
>60 285 (37.35) 53 (6.95) 359 (40.25) 35 (3.92) 1.92 (1.22–2.98)
Sex
Male 301 (39.45) 95 (12.45) 386 (43.27) 92 (10.31) 1.92 (1.30–2.80) 0.15
Female 288 (37.75) 79 (10.35) 362 (40.58) 52 (5.83) 1.33 (0.97–1.83)
Smoking Status
Positive 250 (32.77) 106 (13.89) 301 (33.74) 98 (10.99) 1.96 (1.31–2.91) 0.12
Negative 339 (44.43) 68 (8.91) 447 (50.11) 46 (5.16) 1.30 (0.95–1.81)
Drinking Status
Positive 199 (26.08) 130 (17.04) 284 (31.84) 89 (9.98) 2.09 (1.51–2.88) 0.004
Negative 390 (51.11) 44 (5.77) 464 (52.02) 55 (6.17) 0.95 (0.64–1.45)
Body Mass Index
≤20 129 (16.91) 42 (5.50) 157 (17.60) 41 (4.60) 1.24 (0.77–2.02) 0.43
20< BMI < 28 433 (56.75) 108 (14.15) 546 (61.21) 75 (8.41) 1.82 (1.32–1.50)
≥28 27 (3.54) 24 (3.15) 45 (5.04) 28 (3.14) 1.43 (0.70–2.94)
Family history of cancer c
Positive 31 (4.06) 32 (4.19) 42 (4.71) 38 (4.26) 1.14 (0.58–2.22) 0.28
Negative 558 (73.14) 142 (18.61) 706 (79.15) 106 (11.88) 1.69 (1.29–2.21)
TNM stage
I/II 318 (41.68) 76 (9.96) 748 (83.86) 144 (16.14) 1.62 (1.22–2.13) 0.59
III/IV 271 (35.52) 98 (12.84) 748 (83.86) 144 (16.14) 1.46 (1.03–1.96)

aAdjusted for age, sex, BMI, smoking status, drinking status and family history of CRC as appropriate in a logistic regression model.

b P value of the test for homogeneity between stratum-related ORs for NBS1 (rs2735383GG+GC versus CC genotypes), the values of which were presented in bold, was defined as statistically significant.

cFamily history of cancer represents a history of all malignant tumors in first-degree relatives, which included fathers, mothers, brothers and sisters.